All results

1 results for phase 3 multicenter open label randomized study nab paclitaxel plus gemcitabine

• Study of CTX-009 in Combo w/ Paclitaxel in Pts w/ Unresectable Advanced, Metastatic, Recurrent BTC

  This is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with…

  Ages

  18 Years - N/A

  Sexes

  All